A Tampa Doctor's Medicare Case Just Saved the Government's Main Fraud Weapon

A federal appeals court has reinstated one of the government's most powerful anti-fraud tools after a Florida judge had declared it unconstitutional. On September 1, the Eleventh Circuit Court of Appeals vacated a decision from the Middle District of Florida that had struck down the whistleblower provisions of the False Claims Act, holding that private citizens who bring fraud suits on the government's behalf are not officers of the United States and therefore do not violate the Constitution's Appointments Clause.

The case, United States ex rel. Zafirov v. Florida Medical Associates, began in 2019 when Dr. Clarissa Zafirov sued her former employer, a Medicare Advantage physician practice group, along with two Medicare Advantage insurers. She alleged they systematically submitted false diagnosis codes to inflate Medicare payments. The defendants responded by attacking not the merits but the statute itself, arguing the provision allowing her to sue was unconstitutional.

The stakes extended well beyond one Florida case. The False Claims Act's whistleblower mechanism recovers billions of dollars annually across health care, defense contracting, and other sectors where the federal government spends money. A ruling that the mechanism was unconstitutional, had it stood, would have removed the primary enforcement route for federal fraud recovery nationwide.

How the qui tam mechanism works

The False Claims Act allows a private person, called a relator, to file suit on behalf of the United States against someone who has defrauded the government. That arrangement is known by the Latin term qui tam, shorthand for a phrase meaning one who sues on behalf of the king as well as himself.

The procedure has a distinctive structure. A relator files the complaint under seal, meaning it is not public, and the Justice Department investigates. The government can intervene and take over the case, or it can decline and let the relator proceed alone. If the case recovers money, the relator receives a share, typically between 15 and 30 percent depending on whether the government intervened.

The design addresses an information problem. Fraud against the government is usually visible only to insiders, and the government cannot audit its way to detection across millions of transactions. Employees who see false billing have the information but no incentive to act and substantial reason not to. A financial reward plus anti-retaliation protections changes that calculus.

The statute dates to 1863, enacted during the Civil War in response to contractors defrauding the Union Army. Congress substantially strengthened it in 1986, and the modern version has become the government's dominant fraud recovery tool, particularly in health care.

The constitutional argument

The defendants' argument rested on the Appointments Clause of Article II, which specifies how officers of the United States must be appointed. Principal officers require presidential nomination and Senate confirmation. Inferior officers may be appointed by the president, courts, or department heads.

The argument held that a qui tam relator exercises substantial executive power by litigating on the government's behalf, and that a person exercising such power is an officer of the United States who must be appointed accordingly. A relator is not appointed by anyone. They simply file a lawsuit. If they are officers, the provision allowing them to proceed would be unconstitutional.

The defendants also raised the Take Care Clause, which directs the president to ensure the laws are faithfully executed, and the Vesting Clause, which places executive power in the president. Both arguments contend that allowing a private citizen to control litigation on the government's behalf improperly removes executive authority from the executive branch.

These arguments had gained traction in legal circles in recent years, encouraged by Supreme Court decisions taking a stricter view of executive power and appointments. The Middle District of Florida accepted the Appointments Clause argument and granted judgment for the defendants, making it the first court to strike the provisions down on that basis.

What the Eleventh Circuit held

The appeals court's reasoning turned on what makes someone an officer of the United States. Under Supreme Court precedent, an officer occupies a continuing position established by law. That continuity requirement is what distinguishes an officer from a person who performs a government-related function on a one-time basis.

A qui tam relator, the court concluded, does not occupy such a position. A relator brings a particular case, and when the case ends the relator's involvement ends. There is no ongoing office, no successor, and no position that exists independent of the individual lawsuit. On that basis, relators are not officers and the Appointments Clause does not apply.

The court vacated the district court's judgment and remanded the case so the lower court could consider the remaining constitutional arguments under the Take Care Clause and the Vesting Clause. Those questions were not resolved on appeal.

That remand is an important limitation on what the decision settles. The Appointments Clause challenge is resolved within the Eleventh Circuit. The other two theories remain open, which means the statute's constitutional position is more secure than it was but not finally established.

Why Florida is at the center

That the challenge arose in the Middle District of Florida is not a coincidence. Florida is one of the nation's largest health care markets, with an older population than nearly any other state and correspondingly high Medicare enrollment. Where federal health care dollars are concentrated, fraud enforcement is concentrated too.

Medicare Advantage is the specific program at issue, and it has been a focus of federal enforcement for years. Under Medicare Advantage, private insurers receive fixed per-patient payments from the government adjusted for patient health status, with sicker patients generating higher payments. That structure creates an incentive to document patients as sicker than they are.

The practice is known as risk adjustment upcoding, and allegations that insurers and affiliated physician groups added diagnosis codes not supported by clinical records have generated substantial litigation. Zafirov's allegations fit that pattern.

Florida's federal districts handle a heavy volume of health care fraud cases as a result, and the state has been home to some of the largest Medicare fraud prosecutions in the country. The Eleventh Circuit, which covers Florida, Georgia, and Alabama, therefore sets precedent that governs a disproportionate share of national health care fraud litigation.

What it means for Floridians

The most direct effect is on the integrity of programs Floridians use. Medicare fraud is not victimless. Money extracted through false claims comes from the trust funds that pay for care, and program costs feed into premiums and into the federal budget.

The second effect concerns Florida employees who observe fraud. The False Claims Act's whistleblower provisions include anti-retaliation protections and a financial incentive, and those provisions remain available. A Florida nurse, coder, billing clerk, or physician who sees false claims being submitted retains a legal route to act on it.

The third effect is on Florida's health care industry, which is a major employer. Enforcement risk shapes compliance investment, and organizations facing credible enforcement exposure build compliance programs. A ruling that had eliminated the qui tam mechanism would have reduced that pressure substantially.

For patients, the connection runs through documentation. Risk adjustment fraud involves diagnoses being added to a patient's record that a clinician did not make, which can affect future care decisions and insurance interactions. Patients have a right to review their medical records and to seek corrections.

The broader enforcement picture

The False Claims Act recovers substantial sums annually, with health care consistently the largest category, followed by defense procurement and other federal contracting. The large majority of recoveries originate in qui tam suits rather than in cases the government initiates on its own.

That ratio is the practical argument for the mechanism. Government agencies lack the resources and the visibility to detect most fraud independently, and insiders provide both. Removing the incentive would reduce detection regardless of how much enforcement funding was appropriated.

The counterargument, advanced by business groups including the U.S. Chamber of Commerce, is that the mechanism invites opportunistic litigation, that relators pursue cases the government has declined for good reason, and that defense costs are substantial even when claims fail. Those concerns are real and are the reason the statute includes provisions allowing the government to move to dismiss cases it considers meritless.

The constitutional challenge drew extensive outside participation, with amicus briefs filed by business organizations, taxpayer advocacy groups, and constitutional law scholars on both sides. That volume reflects how much the outcome mattered beyond the parties.

Why the constitutional challenge emerged now

Qui tam provisions have existed in American law since 1863 without successful constitutional challenge, which raises the question of why the argument gained traction in the past few years. The answer lies in a shift in how federal courts approach executive power.

A series of Supreme Court decisions has taken an increasingly strict view of the Appointments Clause and of structural limits on how federal power can be delegated. Those decisions addressed administrative law judges, agency officials, and the removal protections that insulate some officials from presidential control. Each expanded the category of people courts treat as officers requiring proper appointment.

Defense lawyers read that trend and identified qui tam relators as a plausible next target. A relator exercises litigating authority on the government's behalf, controls strategy in many cases, and is accountable to no one in the executive branch beyond the government's limited ability to intervene or seek dismissal. Framed that way, the argument has surface appeal.

The Eleventh Circuit's answer, that officer status requires a continuing position established by law, draws a line that the Supreme Court's prior decisions support. A relator's involvement begins and ends with a single lawsuit, which distinguishes it from every category of official the Court has previously found to be an officer.

What's next

The case returns to the Middle District of Florida, where the district court will consider the Take Care Clause and Vesting Clause arguments the appeals court did not reach. Those rulings will themselves be appealable.

The underlying merits also remain undecided. Zafirov's allegations about false diagnosis codes have not been tested at trial, and the years of constitutional litigation have delayed rather than resolved the factual dispute at the center of the case.

Supreme Court review is plausible at some point. Constitutional challenges to the False Claims Act's qui tam provisions have been raised in multiple circuits, and if courts of appeals reach different conclusions the Supreme Court would have a strong reason to take the question. For now, the provisions stand.